JP2019531093A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531093A5
JP2019531093A5 JP2019536693A JP2019536693A JP2019531093A5 JP 2019531093 A5 JP2019531093 A5 JP 2019531093A5 JP 2019536693 A JP2019536693 A JP 2019536693A JP 2019536693 A JP2019536693 A JP 2019536693A JP 2019531093 A5 JP2019531093 A5 JP 2019531093A5
Authority
JP
Japan
Prior art keywords
binding protein
amino acid
acid sequence
seq
her2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019536693A
Other languages
English (en)
Japanese (ja)
Other versions
JP6976335B2 (ja
JP2019531093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/073768 external-priority patent/WO2018054971A1/en
Publication of JP2019531093A publication Critical patent/JP2019531093A/ja
Publication of JP2019531093A5 publication Critical patent/JP2019531093A5/ja
Application granted granted Critical
Publication of JP6976335B2 publication Critical patent/JP6976335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019536693A 2016-09-22 2017-09-20 組み換え結合タンパク質及びその使用 Expired - Fee Related JP6976335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16190221.8 2016-09-22
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (3)

Publication Number Publication Date
JP2019531093A JP2019531093A (ja) 2019-10-31
JP2019531093A5 true JP2019531093A5 (enExample) 2020-05-21
JP6976335B2 JP6976335B2 (ja) 2021-12-08

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019536693A Expired - Fee Related JP6976335B2 (ja) 2016-09-22 2017-09-20 組み換え結合タンパク質及びその使用

Country Status (20)

Country Link
US (2) US10717772B2 (enExample)
EP (1) EP3515933B9 (enExample)
JP (1) JP6976335B2 (enExample)
KR (1) KR102270315B1 (enExample)
CN (1) CN109790206A (enExample)
AR (1) AR109680A1 (enExample)
AU (1) AU2017331329B2 (enExample)
BR (1) BR112019005587A2 (enExample)
CA (1) CA3036301C (enExample)
CL (1) CL2019000729A1 (enExample)
CO (1) CO2019002609A2 (enExample)
ES (1) ES2953516T3 (enExample)
IL (1) IL265489B (enExample)
MX (1) MX377424B (enExample)
MY (1) MY196882A (enExample)
NZ (1) NZ751689A (enExample)
PH (1) PH12019500596B1 (enExample)
SA (1) SA519401369B1 (enExample)
WO (1) WO2018054971A1 (enExample)
ZA (1) ZA201901592B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020286600A1 (en) * 2019-06-04 2021-12-23 Molecular Partners Ag Recombinant FAP binding proteins and their use
AU2020289080A1 (en) * 2019-06-04 2021-12-23 Molecular Partners Ag Multispecific proteins
EP3980452A1 (en) * 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
CA3138805A1 (en) 2019-06-04 2020-12-10 Johannes Schilling Designed ankyrin repeat domain with improved stability
CN114929730A (zh) 2019-12-11 2022-08-19 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
MX2022013945A (es) * 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
JP2023528204A (ja) 2020-05-14 2023-07-04 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
US20240279309A1 (en) * 2020-05-14 2024-08-22 Molecular Partners Ag Recombinant cd40 binding proteins and their use
WO2022130300A1 (en) 2020-12-16 2022-06-23 Molecular Partners Ag Novel slow-release prodrugs
JP2024509904A (ja) 2021-03-09 2024-03-05 モレキュラー パートナーズ アクチェンゲゼルシャフト 新規なDARPinに基づく多重特異性T細胞エンゲージャ
US20240156980A1 (en) 2021-03-09 2024-05-16 Molecular Partners Ag Protease cleavable prodrugs
EP4304730A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Novel darpin based cd33 engagers
AU2022233791A1 (en) 2021-03-09 2023-09-28 Molecular Partners Ag Novel darpin based cd123 engagers
IL313411A (en) 2021-12-14 2024-08-01 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
CN119731200A (zh) 2022-08-01 2025-03-28 分子合作伙伴股份公司 经电荷修饰设计的重复结构域及其用途
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules
EP4665755A1 (en) 2023-02-17 2025-12-24 Ablynx N.V. Polypeptides binding to the neonatal fc receptor
WO2024179981A1 (en) 2023-02-27 2024-09-06 Molecular Partners Ag Darpins for use in reducing renal accumulation of drugs
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
CN121263440A (zh) 2023-06-06 2026-01-02 分子合作伙伴股份公司 重组cd2结合蛋白及其用途
WO2025146487A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Multispecific binding proteins
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026013280A1 (en) * 2024-07-11 2026-01-15 Johann Wolfgang Goethe-Universität Frankfurt am Main Designed ankyrin repeat proteins binding p53, and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
PT1567641E (pt) * 2001-08-24 2012-08-21 Uvic Industry Partnerships Inc Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
CN101875919A (zh) 2004-11-12 2010-11-03 拜耳先灵医药股份有限公司 重组新城疫病毒
RU2412249C2 (ru) 2005-07-08 2011-02-20 Юниверсити Оф Цюрих Фаговый дисплей с применением котрансляционной транслокации слитых полипептидов
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
CN101970490A (zh) 2007-11-27 2011-02-09 埃博灵克斯股份有限公司 针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽
EP2358746B1 (en) 2008-11-03 2020-09-16 Molecular Partners AG Binding proteins inhibiting the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP2643349B1 (en) * 2010-11-26 2019-09-04 Molecular Partners AG Designed repeat proteins binding to serum albumin
KR20140039203A (ko) 2011-04-29 2014-04-01 얀센 바이오테크 인코포레이티드 Il4/il13 결합 반복 단백질 및 용도
WO2014001442A1 (en) 2012-06-28 2014-01-03 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
JP2015532306A (ja) * 2012-10-15 2015-11-09 チューリッヒ大学 癌治療のための二重特異性her2リガンド
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) * 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

Similar Documents

Publication Publication Date Title
JP2019531093A5 (enExample)
JP2016000731A5 (enExample)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
JP2015537044A5 (enExample)
JP2016052315A5 (enExample)
NZ610075A (en) Cxcr2 binding polypeptides
RU2015120663A (ru) Связывающие белки, содержащие, по меньшей мере, две повторяющиеся области-антагонисты HER2
JP2017529067A5 (enExample)
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
WO2020076977A3 (en) Dll3 single domain antibodies and therapeutic compositions thereof
JP2014088414A5 (enExample)
JP2017504577A5 (enExample)
JP2018521640A5 (enExample)
JP2019506841A5 (enExample)
JP2013541335A5 (enExample)
JP2017029157A5 (enExample)
JP2015535816A5 (enExample)
RU2015144098A (ru) Четырехвалентные биспецифические антитела
JP2020517635A5 (enExample)
JP2015522576A5 (enExample)
JP2013513377A5 (enExample)
JP2018510215A5 (enExample)
JP2015163608A5 (enExample)
RU2012149227A (ru) Биологические материалы, относящиеся к her3
JP2017526632A5 (enExample)